Baseline red blood cell distribution width predicts long-term glycemic remission in patients with type 2 diabetes

Patients with lower baseline RDWs are more likely to maintain a one-year euglycemia remission after short-term CSII. A faster normalization of glucose during treatment and a lower fasting glucose after therapy are correlated with a long-term glucose control.